Current Guidelines in Melanoma Treatment
DermatologyPublished 1 January 2000
Liève Brochez, E. Verhaeghe, François Salès, V. del Mármol, Rika Deraemaecker, Katrien Vossaert
Citations19
SJR quartileQ1
SJR score1.12
SNIP1.14
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
A global picture is offered to the dermatologist of what is currently available in the therapeutic arsenal against melanoma, dealing both with established, internationally well-accepted standard procedures and interventions which are still being investigated.
Abstract
This article focuses on the actual management of cutaneous melanoma, dealing both with established, internationally well-accepted standard procedures and interventions which are still being investigated. It wants to offer a global picture to the dermatologist of what is currently available in the therapeutic arsenal against melanoma.
Keywords
MedicineBiochemistry, Genetics and Molecular Biology
Archives of SurgeryTechnical Details of Intraoperative Lymphatic Mapping for Early Stage Melanoma
4,383 Citations1992Donald L. Morton
Patients with early stage melanoma who have nodal metastases and are likely to benefit from radical lymphadenectomy are identified, with a high degree of accuracy, by a new procedure developed using vital dyes.
Journal of Clinical OncologyInterferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.
2,104 Citations1996J M Kirkwood, M H Strawderman +4 more
IFN alpha-2b is the first agent to show a significant benefit in relapse-free and overall survival of high-risk melanoma patients in a randomized controlled trial.
New England Journal of MedicineInefficacy of Immediate Node Dissection in Stage 1 Melanoma of the Limbs
665 Citations1977Umberto Veronesi, J Adamus +19 more
Elective lymph-node dissection in malignant malanoma of the limbs does not improve the prognosis and is not recommended when patients can be followed at intervals of three months.
Mayo Clinic ProceedingsLymphadenectomy in the Management of Stage I Malignant Melanoma: A Prospective Randomized Study
396 Citations1986Franklin H. Sim, William F. Taylor +2 more
No significant difference was found among the three treatment groups with respect to survival or metastasis-free survival, and multifactorial analysis indicated that the level of invasion and the thickness of the lesion were the most important prognostic factors.
Journal of Clinical OncologyCritical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system.
303 Citations1997Antônio C. Buzaid, Merrick I. Ross +12 more
The analysis showed that the current AJCC staging system for cutaneous melanoma has many inaccuracies that should be modified to conform to published data.
Journal of Clinical OncologyProphylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593.
246 Citations1998Hs Koops, Maurizio Vaglini +9 more
Prophylactic ILP with melphalan cannot be recommended as an adjunct to standard surgery in high-risk primary limb melanoma.
CancerPrimary cutaneous melanoma. Prognostic classification of anatomic location
231 Citations1995Claus Garbe, Petra Büttner +12 more
The aim of the present study was to identify higher and lower risk sites based on multivariate analysis based onMultivariate analysis of Anatomic location for primary cutaneous melanoma patients.
Annals of Surgical OncologyAge as a prognostic factor in the malignant melanoma population
126 Citations1994Paul F. Austin, C. Wayne Cruse +4 more
It is apparent that geriatric patients with melanoma have a worse prognosis than a younger control population, even after the correction for the more commonly cited prognostic factors.
PubMedThe role of surgery in the treatment of nonregionally recurrent melanoma.
75 Citations1993Wong Jh, KA. Skinner +3 more
Cox regression analysis suggests that patients with a solitary metastasis confined to the subcutaneous, nonregional lymph nodes or lung are most likely to benefit from aggressive surgical intervention.
Journal of Surgical OncologyIntroduction: Sentinel lymphadenectomy for patients with clinical stage I melanoma
69 Citations1997Donald L. Morton
It is believed that lymphatic mapping and selective (sentinel) lymph node dissection is an investigational procedure whose therapeutic utility is unproven and should not be used as routine therapy in a community hospital outside the setting of a clinical trial.
British Journal of DermatologyGender and cutaneous melanoma
66 Citations1997John G. Miller, S. Mac Neil
This paper attempts to summarize the evidence for gender being an important factor in melanoma survival by evaluating the contribution of other known prognostic variables such as thickness and site of the primary tumour.
Journal of the American Academy of DermatologyAdjuvant therapy for cutaneous malignant melanoma
35 Citations1997Marie‐France Demierre, Howard K. Koh
The rationale and goals of adjuvant therapy for melanoma are reviewed, and the results of published randomized trials are analyzed to raise many challenging issues in the management of patients with melanoma at high risk of recurrence.
Journal of the American Academy of DermatologyLymphatic mapping and sentinel node biopsy in the management of high-risk melanoma
32 Citations1998FRANK L. GLASS, Jude Cottam +2 more
Seminars in Surgical OncologyRole of radiotherapy and hyperthermia in the management of malignant melanoma
17 Citations1996Rupert Schmidt‐Ullrich, Christopher R. Johnson
Hyperthermia in combination with regionally applied cytotoxic agents or irradiation has produced encouraging enhancements in MM cytotoxicity, however, due to contradicting results, these data need to be validated by additional clinical investigation.